The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects ...

A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...

"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological ...

A medical startup claimed its blood filtering device could cure cancer. But multiple patients who used it died not long after.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.